MIT’s albumin-based cancer vaccine shows promise in clinical trials, yielding robust immune responses, raising hope for effective cancer treatment.
MIT’s Albumin-based cancer vaccine shows promising results in trials
Posted in biotech/medical
Posted in biotech/medical
MIT’s albumin-based cancer vaccine shows promise in clinical trials, yielding robust immune responses, raising hope for effective cancer treatment.